The Centers for Disease Control and Prevention (CDC) has designated April 16-23, 2016 as National Infant Immunization Week (NIIW), an annual observance highlighting the importance of protecting infants from vaccine-preventable diseases and celebrating the achievements of immunization programs and their partners in promoting healthy communities. Across the nation, a variety of educational and promotional events are taking place to raise awareness for childhood immunization and to celebrate healthcare professionals, community champions, and others involved in improving childhood immunization.
As NIIW coincides with the NFID 19th Annual Conference on Vaccine Research (April 18-20, 2016) in Baltimore, MD, the conference organizers have developed a track of presentations and posters discussing maternal and infant immunization. Presentation highlights include:
- Symposium 6: Maternal Immunization
- Safety and Immunogenicity of Tetanus-Diphtheria-Acellular Pertussis Vaccine (Tdap) During Pregnancy (S5)
- Assessing the Feasibility of Monitoring Influenza Vaccine Safety in Pregnant Women Using Text Messaging (S9)
- What is Pneu with Pneumococcal Disease in Children in the Conjugate Vaccine Era (S14)
- Decline of Maternal Measles Antibodies in Infants in Tianjin, China (S16)
- Adverse Events Following DTaP Vaccination in the Vaccine Adverse Event
Reporting System (S7) - Probing the Humoral Immune Response against Respiratory Syncytial Virus to Guide Rational Vaccine Design (P7)
- Measles Immunity and Illness in Tianjin, China (P16)
View the abstracts (through the linked titles above) and attend the Annual Conference on Vaccine Research to network with peers and learn from subject matter experts.
To join the conversation follow us on Twitter (@nfidvaccines), using #ACVR and #NIIW, like us on Facebook, join the NFID Linkedin Group, and subscribe to NFID Updates.
Related Posts
What Have We Learned from COVID-19?
During World Immunization Week, NFID will host the virtual 2021 Annual Conference on Vaccinology Research (ACVR) on April 26-27, 2021, with presentations from leaders in the field of vaccinology, including three keynote lectures on the implications of the COVID-19 pandemic. Read more about the changes and challenges these renowned experts have seen throughout their remarkable careers …
Developing Improved Vaccines for Older Adults
By 2030, the number of adults age 65 years and older in the United States is expected to grow to 71 million—at least 20 percent of the total population. It is particularly important during this stage of life to maintain healthy lifestyles and habits. Receiving recommended immunizations is an essential part of that process.,,
A Forum for Cutting-Edge Vaccine Research Updates
The field of vaccinology continues to expand and innovate in basic science discovery, product development, market introduction, and adoption into immunization programs. Continual achievements are moving the field forward, with the expectation that many current, challenging diseases may become vaccine-preventable or vaccine-treatable in the near future…